Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-21 Sale |
2025-03-24 4:33 pm |
Kura Oncology Inc. | KURA | Hasnain Faheem Director |
22,682 | $8 | $181,456 | 23,983 (Direct) |
View |
2024-06-21 Purchase |
2024-06-24 5:52 pm |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
372,000 | $0.6728 | $250,282 | 5,528,366 (Indirect Direct) |
View |
2024-03-27 Sale |
2024-03-28 6:01 pm |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
23,172 | $1.1554 | $26,773 | 5,156,366 (Indirect Direct) |
View |
2024-01-23 Sale |
2024-01-23 8:37 pm |
Mirati Therapeutics Inc. | MRTX | Hasnain Faheem Director |
24,752 | $0 | $0 | 0 (Direct) |
View |
2023-08-11 Purchase |
2023-08-14 4:41 pm |
Mirati Therapeutics Inc. | MRTX | Hasnain Faheem Director |
10,791 | $27.8 | $299,990 | 25,841 (Indirect Direct) |
View |
2023-03-20 Purchase |
2023-03-22 5:14 pm |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
878,572 | $1.1387 | $1,000,389 | 5,183,862 (Indirect Direct) |
View |
2022-07-15 Purchase |
2022-07-15 4:21 pm |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
138,696 | $7.21 | $999,998 | 3,760,790 (Indirect Direct) |
View |
2022-03-23 Sale |
2022-03-24 4:55 pm |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
19,035 | $8.915 | $169,697 | 3,622,094 (Indirect Direct) |
View |
2020-10-14 Purchase |
2020-10-14 7:28 pm |
Gossamer Bio Inc. | GOSS | Hasnain Faheem Director |
96,520 | $10.36 | $999,995 | 3,478,629 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-21 Exercise |
2025-03-24 4:33 pm |
N/A N/A |
Kura Oncology Inc. | KURA | Hasnain Faheem Director |
22,682 | $6.32 | 23,983 (Direct) |
View |
2025-03-04 Option Award |
2025-03-06 4:03 pm |
N/A 2035-03-03 |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
1,540,000 | $0 | 1,540,000 (Direct) |
View |
2024-06-05 Option Award |
2024-06-07 4:30 pm |
N/A 2034-06-04 |
Kura Oncology Inc. | KURA | Hasnain Faheem Director |
26,000 | $0 | 26,000 (Direct) |
View |
2024-01-02 Option Award |
2024-01-04 5:00 pm |
N/A 2034-01-01 |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
1,312,500 | $0 | 1,312,500 (Direct) |
View |
2023-12-29 Option Award |
2024-01-03 6:18 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Hasnain Faheem Director |
9,702 | $58.75 | 24,752 (Direct) |
View |
2023-11-20 Option Award |
2023-11-22 7:07 pm |
N/A 2033-11-19 |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
437,500 | $0 | 437,500 (Direct) |
View |
2023-07-24 Option Award |
2023-07-26 4:02 pm |
N/A N/A |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
540,176 | $1.82 | 5,314,582 (Indirect) |
View |
2023-07-24 Option Award |
2023-07-26 4:02 pm |
2023-07-24 2028-07-24 |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
135,044 | $0.125 | 5,314,582 (Indirect) |
View |
2023-05-31 Option Award |
2023-06-02 4:49 pm |
N/A 2033-05-30 |
Kura Oncology Inc. | KURA | Hasnain Faheem Director |
26,000 | $0 | 26,000 (Direct) |
View |
2023-05-05 Option Award |
2023-05-09 4:12 pm |
N/A 2033-05-04 |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
750,000 | $0 | 750,000 (Direct) |
View |
2023-03-20 Option Award |
2023-03-22 5:14 pm |
N/A 2033-03-19 |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
544,500 | $0 | 5,183,862 (Direct) |
View |
2023-01-20 Option Award |
2023-01-24 4:17 pm |
N/A 2033-01-20 |
Mirati Therapeutics Inc. | MRTX | Hasnain Faheem Director |
17,049 | $0 | 25,766 (Direct) |
View |
2022-12-07 Option Award |
2022-12-09 5:13 pm |
N/A 2032-12-06 |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
544,500 | $0 | 544,500 (Direct) |
View |
2022-06-21 Option Award |
2022-06-23 4:44 pm |
N/A 2032-06-20 |
Kura Oncology Inc. | KURA | Hasnain Faheem Director |
23,000 | $0 | 23,000 (Direct) |
View |
2022-01-14 Option Award |
2022-01-18 8:32 pm |
N/A 2032-01-13 |
Mirati Therapeutics Inc. | MRTX | Hasnain Faheem Director |
8,862 | $0 | 13,960 (Direct) |
View |
2022-01-06 Option Award |
2022-01-10 4:03 pm |
N/A 2032-01-05 |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
650,000 | $0 | 650,000 (Direct) |
View |
2021-06-22 Option Award |
2021-06-23 5:15 pm |
N/A 2031-06-21 |
Kura Oncology Inc. | KURA | Hasnain Faheem Director |
23,000 | $0 | 23,000 (Direct) |
View |
2021-02-25 Option Award |
2021-03-01 7:40 pm |
N/A 2031-02-25 |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
487,500 | $0 | 3,966,129 (Direct) |
View |
2021-02-10 Option Award |
2021-02-26 7:00 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | Hasnain Faheem Director |
30,000 | $10 | 55,000 (Direct) |
View |
2021-02-10 Exercise |
2021-02-26 7:00 pm |
N/A N/A |
Nuvation Bio Inc. | NUVB | Hasnain Faheem Director |
25,000 | $0 | 55,000 (Direct) |
View |
2021-01-15 Option Award |
2021-01-20 6:14 pm |
N/A 2031-01-14 |
Mirati Therapeutics Inc. | MRTX | Hasnain Faheem Director |
5,162 | $0 | 8,162 (Direct) |
View |
Ownership |
2020-06-30 6:03 pm |
N/A N/A |
Panacea Acquisition Corp | PANA | Hasnain Faheem Director |
0 | $0 | 25,000 (Direct) |
View |
2020-06-24 Option Award |
2020-06-26 4:07 pm |
N/A 2030-06-23 |
Kura Oncology Inc. | KURA | Hasnain Faheem Director |
23,000 | $0 | 23,000 (Direct) |
View |
2020-06-17 Option Award |
2020-06-18 4:51 pm |
N/A 2030-06-16 |
Gossamer Bio Inc. | GOSS | Hasnain Faheem Director |
47,000 | $0 | 47,000 (Direct) |
View |